INOMAX hospitals
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
6 State Route 173, Clinton, New Jersey, ...Phone Number
(908) 238-6600Website
www.inomax.comRevenue
$77 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About INOMAX hospitals
Mallinckrodt Pharmaceuticals specializes in the production of INOmax, a nitric oxide gas for inhalation, primarily aimed at treating term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. Their offerings include innovative delivery systems that emphasize flexibility and automation, along with a comprehensive Total Care service that provides 24/7 support, device education, and technical assistance. The company is committed to improving patient outcomes in neonatal intensive care units (NICUs) through effective treatment solutions and ongoing support. With a legacy of service and reliability, Mallinckrodt continues to be a leader in the market for nitric oxide delivery systems.Explore more
Popular SearchesINOMAX hospitalsIno Therapeutics IncIno Therapeutics LLCINO TherapeuticsInomaxSIC Code 28,283NAICS Code 32,325Show more
INOMAX hospitals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is INOMAX hospitals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on INOMAX hospitals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
INOMAX hospitals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when INOMAX hospitals launches new products
Check out if INOMAX hospitals is spiking on competitors!
Check if INOMAX hospitals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once INOMAX hospitals has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at INOMAX hospitals
Click to see if INOMAX hospitals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to INOMAX hospitals
Compare insights from companies similar to INOMAX hospitals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$23M
51-200
Private
-
-
EA
Erin ArcarioDirector, US People Analytics and Human Resources Projects and Chief of Staff
Company Profile Activity
Activity Insights
INOMAX hospitals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INOMAX hospitals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INOMAX hospitals.
INOMAX hospitals Tech Stack
A closer look at the technologies used by INOMAX hospitals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INOMAX hospitals
Sign Up For FreeTo access detailed company insights
Mallinckrodt Pharmaceuticals specializes in the production of INOmax, a nitric oxide gas for inhalation, primarily aimed at treating term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. Their offerings include innovative delivery systems that emphasize flexibility and automation, along with a comprehe... Read More
